Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinoma
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 29 (5), 737-740
- https://doi.org/10.1016/s0959-8049(05)80357-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Complete spontaneous regression in metastatic renal cell carcinoma — an update and reviewWorld Journal of Urology, 1991
- Estrogen and progesterone binding sites in renal cell carcinomaUrology, 1989
- Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Adjuvant Medroxyprogesterone Acetate and Steroid Hormone Receptors in Category M0 Renal Cell Carcinoma. An Interim Report of a Prospective Randomized StudyJournal of Urology, 1986
- Steroid hormone receptors in normal and malignant human renal tissue: Relationship with progestin therapyThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- Antiestrogen-Binding Sites Distinct from the Estrogen Receptor: Subcellular Localization, Ligand Specificity, and Distribution in Tissues of the Rat*Endocrinology, 1983
- The Natural History of Metastatic Renal Cell Carcinoma: A Computer AnalysisJournal of Urology, 1978
- Renal Cell Carcinoma: Natural History and Results of TreatmentJournal of Urology, 1978
- Current status of the therapy of advanced renal carcinomaJournal of Surgical Oncology, 1977